Mattias Mandorfer

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Jonel Trebicka, Javier Fernández, Mária Papp et al. · Journal of Hepatology · 2020 · 504 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

Mattias Mandorfer, Simona Bota, Philipp Schwabl et al. · Gastroenterology · 2014 · 371 citations

Medicine, Pharmacology, Pharmacotherapy +14

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

Thomas Reiberger, Arnulf Ferlitsch, B.A. Payer et al. · Journal of Hepatology · 2012 · 322 citations

Veterinary Medicine, Immunology, Pharmacology +11

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Mattias Mandorfer, K Kozbial, Philipp Schwabl et al. · Journal of Hepatology · 2016 · 301 citations

Life Sciences, Immunology, Infectious Diseases +16

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 300 citations · Full text

Pharmacy, Immunology, Oncology +17